资讯
内科
心血管
肿瘤
内分泌
普通内科
消化
呼吸
神经科
传染科
精神心理
肾内科
风湿免疫
血液科
老年医学
外科
头颈外科
胃肠外科
血管外科
肝胆胰外
骨科
普通外科
胸心外科
神经外科
泌尿外科
烧伤科
整形美容
麻醉疼痛
专科科室
罕见病
康复医学
药械
儿科
耳鼻咽喉
口腔科
眼科
政策人文
营养全科
预防公卫
妇产科
中医科
急重症
皮肤性病
影像放射
转化医学
检验病理
护理
热点
临床研究
研究设计
人工智能
智慧医疗
论文基金
医学科普
药物经济
医生集团
职业安全
患者招募
医学科研
公司产业
医学英语
MedSci动态
指南
按科室浏览
肿瘤科
心血管
传染科
妇产科
神经科
儿科
呼吸
内分泌科
血液科
消化
更多科室
工具
临床工具
临床指南
医学计算与公式
ICD-10/ICD-11疾病编码
医讯达
直播
话题
公开课
精品课
科研工具
期刊数据库查询
期刊智能选择
全球基金查询
文献查询
SCI写作宝典
生物医药大词典
其他工具
下载App使用方便更快捷
Medsci 梅斯搜索
公开课
精品课
服务
科研数智化
直播,公开课与精品课
科研加速器
研究者发起的临床研究(IIS)支持
真实世界研究解决方案
药物经济学
医保准入事务
研究方案设计
数据库建立与管理
药物警戒(PV)
真实世界研究执行
数据统计分析
数字化学术传播解决方案
多渠道营销(MCM)
产品医学策略
学术传播(APO)
其它
积分商城
FAQS
map
#利弊#
39篇内容 | 1850人围观
关注话题
话题活跃用户
#
插入话题
插入图片
评论
最新
最热
GetTopicDetailResponse(id=d8c6322986a, topicName=利弊, introduction=利弊, content=null, image=null, comments=39, allHits=1850, url=https://h5.medsci.cn/topic?id=32298, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=23970, tagList=[TagDto(tagId=23970, tagName=利弊)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1744809, encodeId=aa771e44809f6, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=JCO:西妥昔单抗联合放化疗治疗HIV相关肛管癌 利弊皆有!, objectType=article, longId=99749, objectId=79f199e49ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79f199e49ce, replyNumber=0, likeNumber=59, createdTime=2018-03-15, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79f199e49ce, moduleTitle=JCO:西妥昔单抗联合放化疗治疗HIV相关肛管癌 利弊皆有!, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=79f199e49ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744802, encodeId=f0d51e448020f, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=取消医生编制:利弊难测的双刃剑, objectType=article, longId=74442, objectId=63f3e444232, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63f3e444232, replyNumber=0, likeNumber=66, createdTime=2017-05-31, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63f3e444232, moduleTitle=取消医生编制:利弊难测的双刃剑, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=63f3e444232)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744804, encodeId=4bb71e4480421, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=【盘点】补充硒对人体健康有啥利弊?, objectType=article, longId=78148, objectId=b32ae81485e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b32ae81485e, replyNumber=0, likeNumber=81, createdTime=2017-05-07, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b32ae81485e, moduleTitle=【盘点】补充硒对人体健康有啥利弊?, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b32ae81485e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744803, encodeId=d7e11e4480312, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=JAMA Surg:抗凝治疗小腿孤立性DVT利弊分析, objectType=article, longId=74845, objectId=363be48452b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=363be48452b, replyNumber=0, likeNumber=74, createdTime=2016-09-03, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=363be48452b, moduleTitle=JAMA Surg:抗凝治疗小腿孤立性DVT利弊分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=363be48452b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744801, encodeId=46a71e448017d, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=J Sex Med:性功能辅助药对男性身体利弊的研究, objectType=article, longId=62209, objectId=11656220970, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11656220970, replyNumber=0, likeNumber=86, createdTime=2016-10-21, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11656220970, moduleTitle=J Sex Med:性功能辅助药对男性身体利弊的研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=11656220970)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744798, encodeId=6aeb1e447987b, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=NEJM:早产儿早期接受全身性糖皮质激素,利弊皆有, objectType=article, longId=57293, objectId=83695e293c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83695e293c9, replyNumber=0, likeNumber=59, createdTime=2016-07-01, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83695e293c9, moduleTitle=NEJM:早产儿早期接受全身性糖皮质激素,利弊皆有, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=83695e293c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744799, encodeId=3d8f1e4479900, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=NEJM:强化降压,利弊皆有, objectType=article, longId=58599, objectId=ba33585993b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba33585993b, replyNumber=0, likeNumber=70, createdTime=2016-09-19, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba33585993b, moduleTitle=NEJM:强化降压,利弊皆有, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ba33585993b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744800, encodeId=46aa1e4480051, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=蜂蜜的利弊——你真的了解吗?, objectType=article, longId=58975, objectId=d658589e556, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d658589e556, replyNumber=0, likeNumber=57, createdTime=2016-03-23, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d658589e556, moduleTitle=蜂蜜的利弊——你真的了解吗?, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d658589e556)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744797, encodeId=56211e447978d, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=妊娠期用药仍需要在权衡利弊,降低出生缺陷, objectType=article, longId=54458, objectId=a6cb544583e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6cb544583e, replyNumber=0, likeNumber=85, createdTime=2016-02-23, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6cb544583e, moduleTitle=妊娠期用药仍需要在权衡利弊,降低出生缺陷, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a6cb544583e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744796, encodeId=c38e1e4479606, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=如何权衡不同双联抗血小板疗程的利弊?, objectType=article, longId=51603, objectId=ee055160375, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee055160375, replyNumber=0, likeNumber=99, createdTime=2015-12-23, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee055160375, moduleTitle=如何权衡不同双联抗血小板疗程的利弊?, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ee055160375)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744795, encodeId=29531e44795c7, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=NEJM:FDA审批Bedaquiline—耐药结核病的利弊权衡, objectType=article, longId=39588, objectId=e35439588ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e35439588ea, replyNumber=0, likeNumber=71, createdTime=2015-01-06, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e35439588ea, moduleTitle=NEJM:FDA审批Bedaquiline—耐药结核病的利弊权衡, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e35439588ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744794, encodeId=20481e44794d9, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=Nature:埃博拉试验疗法的利弊, objectType=article, longId=39245, objectId=ccc9392453c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccc9392453c, replyNumber=0, likeNumber=50, createdTime=2015-07-21, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccc9392453c, moduleTitle=Nature:埃博拉试验疗法的利弊, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ccc9392453c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744793, encodeId=52c71e447932f, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=BMJ:乳腺癌钼靶筛查利弊难评, objectType=article, longId=37280, objectId=5ef53e2801a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ef53e2801a, replyNumber=0, likeNumber=74, createdTime=2014-08-04, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ef53e2801a, moduleTitle=BMJ:乳腺癌钼靶筛查利弊难评, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5ef53e2801a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744791, encodeId=a49a1e44791ce, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=NEJM:围手术期心梗治疗的“阴阳利弊”---POISE-2研究述评, objectType=article, longId=34004, objectId=b9633400470, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9633400470, replyNumber=0, likeNumber=75, createdTime=2014-06-21, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9633400470, moduleTitle=NEJM:围手术期心梗治疗的“阴阳利弊”---POISE-2研究述评, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b9633400470)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744790, encodeId=6e431e447905d, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=BMJ:应用奥司他韦(达菲)需权衡利弊, objectType=article, longId=33652, objectId=c6123365263, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6123365263, replyNumber=0, likeNumber=66, createdTime=2014-12-15, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6123365263, moduleTitle=BMJ:应用奥司他韦(达菲)需权衡利弊, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c6123365263)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744792, encodeId=10d21e44792e4, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=Eur Heart J:溶栓治疗对急性肺栓塞患者利弊并存, objectType=article, longId=36403, objectId=5e9136403a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e9136403a7, replyNumber=0, likeNumber=71, createdTime=2015-01-28, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e9136403a7, moduleTitle=Eur Heart J:溶栓治疗对急性肺栓塞患者利弊并存, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5e9136403a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744789, encodeId=410e1e4478912, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=NSCLC:同药维持和换药维持利弊之争, objectType=article, longId=19177, objectId=26df191e781, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26df191e781, replyNumber=0, likeNumber=68, createdTime=2013-06-21, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26df191e781, moduleTitle=NSCLC:同药维持和换药维持利弊之争, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=26df191e781)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744788, encodeId=26be1e44788ba, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=NEJM:乳房X光筛查的利弊再起争议, objectType=article, longId=11943, objectId=88cd119435d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88cd119435d, replyNumber=0, likeNumber=65, createdTime=2013-07-16, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88cd119435d, moduleTitle=NEJM:乳房X光筛查的利弊再起争议, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=88cd119435d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1744787, encodeId=5cc21e44787cf, content=<a href='/topic/show?id=d8c6322986a' target=_blank style='color:#2F92EE;'>#利弊#</a>, objectTitle=如何权衡ADT的“利弊”?, objectType=article, longId=2348, objectId=86c02348ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86c02348ce, replyNumber=0, likeNumber=63, createdTime=2011-06-29, rootId=0, userName=lujian, userId=8a8135449354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86c02348ce, moduleTitle=如何权衡ADT的“利弊”?, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=86c02348ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯话题小助手
关注
已关注
利弊
2020-05-29
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
JCO:西妥昔单抗联合放化疗治疗HIV相关肛管癌 利弊皆有!
59
0
2018-03-15
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
取消医生编制:利弊难测的双刃剑
66
0
2017-05-31
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
【盘点】补充硒对人体健康有啥利弊?
81
0
2017-05-07
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
JAMA Surg:抗凝治疗小腿孤立性DVT利弊分析
74
0
2016-09-03
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
J Sex Med:性功能辅助药对男性身体利弊的研究
86
0
2016-10-21
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
NEJM:早产儿早期接受全身性糖皮质激素,利弊皆有
59
0
2016-07-01
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
NEJM:强化降压,利弊皆有
70
0
2016-09-19
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
蜂蜜的利弊——你真的了解吗?
57
0
2016-03-23
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
妊娠期用药仍需要在权衡利弊,降低出生缺陷
85
0
2016-02-23
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
如何权衡不同双联抗血小板疗程的利弊?
99
0
2015-12-23
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
NEJM:FDA审批Bedaquiline—耐药结核病的利弊权衡
71
0
2015-01-06
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
Nature:埃博拉试验疗法的利弊
50
0
2015-07-21
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
BMJ:乳腺癌钼靶筛查利弊难评
74
0
2014-08-04
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
NEJM:围手术期心梗治疗的“阴阳利弊”---POISE-2研究述评
75
0
2014-06-21
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
BMJ:应用奥司他韦(达菲)需权衡利弊
66
0
2014-12-15
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
Eur Heart J:溶栓治疗对急性肺栓塞患者利弊并存
71
0
2015-01-28
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
NSCLC:同药维持和换药维持利弊之争
68
0
2013-06-21
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
NEJM:乳房X光筛查的利弊再起争议
65
0
2013-07-16
回复
lujian
(审核中...)
关注
已关注
前往app查看评论内容
#利弊#
如何权衡ADT的“利弊”?
63
0
2011-06-29
回复
共39条
首页
上一页
下一页
尾页
页码:
2
/2页
20条/页
扫描二维码下载梅斯医学APP
map
科室
订阅+
更多科室
工具
服务
map
map